pharmaphorum mediaSummit Therapeutics to raise funds for Duchenne and C diff drugsSummitSummit Therapeutics to raise funds for Duchenne and C diff drugs
About this event
UK biotech firm Summit Therapeutics is preparing a US share offer to raise funding for its research programmes. The Oxford-based company is already listed on London's AIM market, but will now also join the NASDAQ, where it hopes to raise around $33 million via an initial public offering next week.
Its two lead candidates are of two mid-stage drugs, SMT C1100 for Duchenne Muscular Dystrophy (DMD) and SMT19969 for C difficile infections.
Summit Therapeutics to raise funds for Duchenne and C diff drugs is a summit from pharmaphorum media focused on Data. The event is scheduled for Thursday, March 5, 2015. UPCOMING provides an independent event listing and directs attendees to pharmaphorum media's website to complete registration or viewing.
Topics covered
Frequently asked questions
Who is hosting Summit Therapeutics to raise funds for Duchenne and C diff drugs?
Summit Therapeutics to raise funds for Duchenne and C diff drugs is hosted by pharmaphorum media.
When is Summit Therapeutics to raise funds for Duchenne and C diff drugs?
Summit Therapeutics to raise funds for Duchenne and C diff drugs is scheduled for Thursday, March 5, 2015.
Where does registration take place?
Registration or viewing is completed on pharmaphorum media's website.
What format is this event?
This is an online summit.
Which topics does this event cover?
The event covers Data.
